EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...

Exelixis, Inc. (Nasdaq: EXEL) today announced that the company has entered into a clinical development collaboration with Merck, known as MSD outside of the United States and Canada, to supply ...

NHS rolls out “one minute” immunotherapy jab NHS England announced that it was rolling out a new injectable form of the ...

The treatment, now being offered at Royal Cornwall Hospitals NHS Trust (RCHT), is an injectable form of pembrolizumab (Keytruda).

Detailed price information for Pyxis Oncology Inc (PYXS-Q) from The Globe and Mail including charting and trades.

Dr Hilary Jones has praised a new NHS injection that not only takes 60 seconds to administer but is also set to help tens of ...

Vast numbers of NHS patients and staff throughout England are expected to reap the benefits of the injection, reports the Mirror. Dr Hilary explained: "It is replacing an intraven ...

I had read countless legal documents about the world's bestselling drug. But it took a trip to Latin America to see how scarcity shapes life and death decisions.

The Gibraltar Health Authority has begun using the subcutaneous form of Pembrolizumab for the treatment of some cancers, with ...

A new injectable form of a key cancer drug could free up more than 2,000 hours of hospital time a year across East Yorkshire and North Lincolnshire. Humber Health Partnership (HHP) is one of the first ...

Health minister hopes a key injectable cancer drug will be available in all five trusts "as soon as possible".

Samsung Bioepis Co., Ltd. announced today that the Phase 1 study on SB27, a proposed biosimilar to Keytruda 1 (pembrolizumab), has met its primary pharmacokinetics (PK) endpoints. The randomized, ...